Levodopa‐Induced Jaw and Facial Dystonia in a Case of Progressive Supranuclear Palsy with Blepharospasm

Movement Disorders Clinical PracticeEarly View CASE REPORT Levodopa-Induced Jaw and Facial Dystonia in a Case of Progressive Supranuclear Palsy with Blepharospasm Halil Onder MD, Corresponding Author Halil Onder MD [email protected] orcid.org/0000-0002-1823-2278 Neurology Clinic, Etlik City Hospital, Ankara, Turkey Correspondence to: Dr. Halil Onder, Neurology Clinic, Etlik City Hospital, Ankara, Turkey; E-mail: [email protected]Search for more papers by this authorSelcuk Comoglu MD, Selcuk Comoglu MD Neurology Clinic, Etlik City Hospital, Ankara, TurkeySearch for more papers by this author Halil Onder MD, Corresponding Author Halil Onder MD [email protected] orcid.org/0000-0002-1823-2278 Neurology Clinic, Etlik City Hospital, Ankara, Turkey Correspondence to: Dr. Halil Onder, Neurology Clinic, Etlik City Hospital, Ankara, Turkey; E-mail: [email protected]Search for more papers by this authorSelcuk Comoglu MD, Selcuk Comoglu MD Neurology Clinic, Etlik City Hospital, Ankara, TurkeySearch for more papers by this author First published: 11 September 2023 https://doi.org/10.1002/mdc3.13881 Potential conflict of interest: The authors declare that there is no conflict of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Jahngir MU, Ameer MA, Patel BC. Meige Syndrome. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. 2Pandey S, Sharma S. Meige's syndrome: history, epidemiology, clinical features, pathogenesis and treatment. J Neurol Sci 2017; 15(372): 162–170. 3Gautam P, Bhatia MS, Kaur J, Rathi A. Meige's syndrome. Ind Psychiatry J 2016; 25(2): 232–233. 4Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 2017; 32(6): 853–864. 5Espay AJ, Morgante F, Merola A, et al. Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts. Ann Neurol 2018; 84(6): 797–811. 6Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A. Dyskinesia in multiple system atrophy and progressive supranuclear palsy. J Neural Transm (Vienna) 2019; 126(7): 925–932. 7Tee TY, Khoo CS, Norlinah MI. Prominent oromandibular dystonia as levodopa-induced dyskinesia in idiopathic Parkinson's disease. Mov Disord Clin Pract 2019; 6(4): 330–331. 8Pfeiffer RF, LeDoux MS. Levodopa-induced lateral jaw deviation dystonia. Parkinsonism Relat Disord 2015; 21(7): 808. 9Magrinelli F, Rajapaksha I, Kobylecki C, et al. Reply to: juvenile PLA2G6-parkinsonism due to Indian ‘Asian’ p.R741Q mutation, and response to STN DBS. Mov Disord 2022; 37(3): 658–662. 10Barclay CL, Lang AE. Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997; 62(4): 352–356. 11Tan EK, Chan LL, Wong MC. Levodopa-induced oromandibular dystonia in progressive supranuclear palsy. Clin Neurol Neurosurg 2003; 105(2): 132–134. 12Wenning GK, Geser F, Poewe W. The ‘risus sardonicus’ of multiple system atrophy. Mov Disord 2003; 18(10): 1211. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation